Article | Open | Published:

# The dynamics of the antibiotic resistome in the feces of freshly weaned pigs following therapeutic administration of oxytetracycline

## Abstract

In this study, shotgun metagenomics was employed to monitor the effect of oxytetracycline, administered at a therapeutic dose, on the dynamics of the microbiota and resistome in the feces of weaned pigs. Sixteen weaning pigs were assigned to one of two treatments including standard starter diet for 21 days or antibiotic-supplemented diet (10 g oxytetracycline/100 kg body weight/day) for 7 days, followed by 14 days of standard starter diet. Feces were collected from the pigs on days 0, 8, and 21 for microbiota and resistome profiling. Pigs receiving oxytetracycline exhibited a significantly greater richness (ANOVA, P = 0.034) and diversity (ANOVA, P = 0.048) of antibiotic resistance genes (ARGs) than the control pigs. Antibiotic administration significantly enriched the abundances of 41 ARGs, mainly from the tetracycline, betalactam and multidrug resistance classes. Compositional shifts in the bacterial communities were observed following 7 days of antibiotic adminstration, with the medicated pigs showing an increase in Escherichia (Proteobacteria) and Prevotella (Bacteroidetes) populations compared with the nonmedicated pigs. This might be explained by the potential of these taxa to carry ARGs that may be transferred to other susceptible bacteria in the densely populated gut environment. These findings will help in the optimization of therapeutic schemes involving antibiotic usage in swine production.

## Introduction

Antibiotics have been used for decades in swine and other livestock production for both therapeutic (e.g. treatment of specific diseases) and nontherapeutic (growth promotion) purposes1,2. For years, nontherapeutic (low-dose) application of antibiotics as growth promoters was linked with beneficial effects; however, there is data that supports the fact that this practice possible contributes to the emergence of antimicrobial-resistant bacteria, thus exacerbating the problem of antibiotic resistance in animal and human pathogens2,3,4,5,6,7,8,9,10. Additionally, it is likely that therapeutic doses of antibiotics can be subinhibitory antibiotic concentrations for some host-associated bacteria, enhancing the selection for antibiotic resistance genes (ARGs) and the horizontal transfer of these genes4.

Tetracyclines are a broad spectrum and relatively low cost group of antibiotics, of which tetracycline, chlortetracycline and oxytetracycline are frequently employed in veterinary medicine5,11,12. Tetracyclines have several therapeutic indications, which are associated with various infections in food-producing animals (e.g., infections caused by Mycoplasma, Chlamydia, Pasteurella, Clostridium, Ornithobacterium rhinotracheale, and some protozoa11,12). In food-producing species, including swine, first-generation tetracyclines (e.g., oxytetracycline) are most frequently employed. Therapeutic indications in animals comprise respiratory infections, dermal and soft tissue infections, peritonitis, metritis, and other enteric infections5,8,11. The recommended dosage of oxytetracycline for pigs for therapeutic purposes is 40 mg oxytetracycline hydrochloride/kg body weight (KBW)/day, for 7–10 days. In numerous countries, tetracyclines are included in feed, not just for therapeutic purposes but also at subtherapeutic doses to promote growth in swine2,3,5,11,13. Consumer apprehension associated with emerging bacterial resistance has led to antibiotics being no longer used for such purposes in some regions including the EU, the USA, New Zealand, Chile, Bangladesh, South Korea, and Vietnam14,15. However, nontherapeutic administration of tetracyclines for growth promotion purposes is still allowed in many other countries3,11,12.

We hypothesized that a therapeutic application of antibiotic could cause detectable and long term changes on pig fecal microbiota and resistome composition. To test this theory, we investigated the effect of a 7-day oxytetracycline administration at therapeutic dose and its withdrawal, on the diversity and abundance of the fecal antibiotic resistome and microbiota in freshly weaned pigs using a whole-metagenome shotgun sequencing approach. The findings of this study have important implications for swine production and public health, since there is a paucity of research on the effects of therapeutic doses of antibiotics on the diversity and abundance of the gut microbiota as well as the antibiotic resistome.

## Results

Within the first week of the feeding trial, three pigs (two from the antibiotic-medicated group and one from the control group) showed symptoms of E. coli infection and were treated once with the anti-inflammatory drug dexamethasone as well as with fluoroquinolone (3rd generation, 3 mL/100 KBW) for three consecutive days. Therefore, metagenome data from these animals were not included in the downstream data processing.

### Sequencing

Sequencing generated approximately 600 million sequences, ranging from 8.18 to 19 million per sample (Supplementary Table S1). The average quality score (Phred scores) across all the samples was 35.11 and ranged from 32.6 to 40. Phred scores greater than Q30 indicated that there was a less than 0.1% chance that a base was called incorrectly. Quality filtering of datasets resulted in the removal of 0.19% of the reads with Phred score <33 as well as removal of 2.5% of the reads that were classified as belonging to the host and PhiX genome.

### Resistome diversity and composition of the gut

Using the MEGARes database with a 90% gene cutoff fraction, 490,000 reads were aligned to 648 AMR genes across both groups. The AMR genes were classified into 19 unique classes of resistance, 49 mechanisms and 175 groups (Supplementary Tables S2 and S3). Following antibiotic administration for 7 days, the pigs receiving oxytetracycline were enriched in ARGs and had high diversity of ARGs (Fig. 1). Alpha diversity analysis revealed that the overall size of the resistome (i.e., the number of unique ARGs) was significantly affected (ANOVA, P < 0.05) by the day as well as by the oxytetracycline treatment (Fig. 1), with the highest resistome diversity in both groups observed on day 0 and the lowest diversity observed at the end of the trial. Linear mixed-effect analysis of the diversity indices showed a significant differences in the richness (P = 0.034) and diversity (P = 0.048, Shannon index) of ARGs between the pigs of the control and antibiotic-medicated groups from day 0 to day 8 but not at day 21 following the withdrawal period.

In a further assessment of the resistome composition and diversity level, NMDS analysis based on the Bray-Curtis dissimilarity metric displayed a clear separation of the medicated animals from the nonmedicated animals samples at day 8 and 21 (Fig. 2). The two-way PerMANOVA test followed by pairwise post-hoc comparisons (https://github.com/leffj/mctoolsr/) showed a significant difference in the profile of the relative abundance of ARGs between the treatments for both day 8 (q = 0.038) and day 21 (q = 0.010) but not for day 0 (q = 0.262). While the medicated pigs medicated with oxytetracycline clearly diverged from the nonmedicated pigs at day 8 according to the NMDS ordination, the ARGs profile in the medicated group at day 21 tended to be closer to the nonmedicated group, indicating a resilience of the bacterial communities carrying ARGs from antibiotic perturbation.

Tetracycline resistance was the predominant class to which the reads were aligned, with beta-lactam resistance constituting most of the remaining reads (Fig. 3a). In fact, regardless of antibiotic medication, all the samples harbored a diverse range of ARGs (Fig. 3). In the tetracycline class, the main mechanism of resistance detected was through resistance ribosomal protection proteins (RRPPs). The main mechanism of resistance within the beta-lactam class was Class A beta-lactamases (CABLs). In addition to CABLs and RRPPs, the other predominant mechanisms of resistance were multidrug efflux pumps, multidrug resistance regulators, macrolide resistance efflux pumps, and lincosamide nucleotidyltransferases (Fig. 3b).

Differential abundance analysis revealed that from day 0 to day 8 (the last day of antibiotic administration), oxytetracycline feeding significantly enriched the abundances of 41 ARGs (q < 0.05), which were mainly from the tetracycline, beta-lactam and multidrug resistance classes (Fig. 4a, Supplementary Table S4). Further analysis of the samples at day 21, two weeks after the withdrawal of antibiotic administration, showed that 17 ARGs remained significantly more abundant (q < 0.05) in antibiotic-treated pigs than in the control group (Fig. 4b, Supplementary Table S5).

### Microbiome diversity and gut composition

Comparison of microbial community structure using the alpha diversity indices revealed that the total number of detected species (richness) as well as their diversity (Shannon) were lower for the communities in medicated animals than for the control animals during the antibiotic treatment period (day 0 to day 8) (Fig. 5), with the values decreasing further during the withdrawal period (Fig. 5).

The temporal shifts of bacterial communities were relatively similar to those of ARGs, with the medicated pigs diverged from the nonmedicated pigs (Fig. 6). In fact, analysis of the community structures showed significant differences between medicated and nonmedicated animals after antibiotic treatment (day 8, post hoc two-way PerMANOVA, q = 0.04). Taken together, these data indicate that oxytetracycline administration reduced both the bacterial community’ richness and diversity in the gut microbiota of the pigs and that the gut bacterial community diversity did not fully recover, despite the withdrawal of the antibiotic for two weeks.

Taxonomic profiling of the fecal samples were performed to see whether or not the (temporal) changes in ARG profiles were associated with the changes in the fecal microbial population structure in response to oxytetracycline administration. The distribution of the most abundant phyla and genera in the feces over the course of the study can be seen in Fig. 7. The results showed that among the dominant group of taxa, Firmicutes exhibited low relative abundance, while the phyla Bacteroidetes and Proteobacteria exhibited increased abundances, in the medicated animals (q < 0.05, Fig. 7a, Supplementary Tables S6 and S7) on day 8 and day 21. Interestingly, the enrichment of Bacteroidetes in the feces of medicated animals was proportional to the decrease in Firmicutes abundance (Fig. 7b). This oxytetracycline-derived shift to a Bacteroidetes-dominant microbial community was also observed when the medicated animals were compared to the pretreatment animals.

Differential abundance analysis of the species-level taxonomic assignments revealed significant differences between the medicated and nonmedicated pigs microbiota. Many taxa exhibited relatively decreased abundances with antibiotic administration, most of which from the phylum Firmicutes (Fig. 8). However, the abundances of representatives of the genera Escherichia−Shigella, Acidaminococcus, Marvinbryantia, Prevotella, Blautia, Parabacteroides, Paludibacter, Megasphaera, Clostridium, Sporobacterium and Achromobacter and of an unclassified Lachnospiraceae were significantly enriched (q < 0.05) in the fecal microbiota of the antibiotic treated animals (Fig. 8, Supplementary Tables S8 and S9). The relative increase in the abundances of Prevotella spp. and Parabacteroides spp. was reflected by an overall increase in proportions of the phylum Bacteroidetes in the oxytetracycline-treated animals. The change in proportion of Prevotella was particularly notable; while this genus was among the low-abundance taxonomic groups during the pretreatment period, the abundance increased consistently over time, and Prevotella remained by far the most dominant taxonomic group until the end of the feeding trial.

## Discussion

One of the important questions in microbiome research relates to the extent to which production practices and environmental factors affect microbiota transmission, acquisition, and function16. To address this question, one approach used is experimental manipulation of gut systems to measure the impact, such as the effect of diet or antibiotic use on the microbiome16. In the current study, we employed shotgun metagenomics to explore the effect of in-feed oxytetracycline and its withdrawal on the dynamics of the fecal microbiota composition as well as the microbial resistome in postweaned swine over a 21-day period. Oxytetracycline is one of the most frequently employed antibiotic compounds in swine production in the European Union and the United States, with use in disease prevention as well as feed efficiency improvement11,12,14.

The biodiversity analysis results revealed the presence of diverse resistance genes in the fecal microbiome of the pigs, even in the absence of antibiotic pressure. In fact, ARG types, including genes encoding resistance to beta-lactams and tetracycline as well as multidrug resistance genes, were highly abundant in both medicated and nonmedicated pigs. Although there was a similarity in ARG classes detected in this study with those reported for human feces and the environmental samples17, the prevalent ARGs detected in this study were different from those found in human feces, river water, and sediments17. This finding supports the theory that specific ARGs are associated with particular environments and are not randomly distributed18 and that the constant selective pressure of antibiotic administration for over 50 years in swine production seems to have led to a high background level of gut resistome in swine6.

Oxytetracycline administration resulted in a detectable increase in the diversity and abundance of resistance genes that was even higher than the large background resistance, though the gut resistome diversity mainly recovered after two weeks of antibiotic withdrawal. Consistent with our results, Noyes et al.19 and Looft et al.6 observed an increase in the abundance and diversity of antimicrobial resistance genes in feedlot pens, where animals were administered tetracycline and ASP20 during feeding. As expected, tetracycline resistance genes were significantly enriched in the feces of the medicated animals in the current study.

Generally, efflux pumps, ribosome protection and tetracycline modification are the primary means via which bacteria are afforded resistance to tetracycline12. Consistent with our findings, ribosome protection seems to be the most prevalent of these mechanisms in nature20. The spread of the ribosomal protection proteins determinants such as tetQ and tetM throughout eubacteria via lateral gene transfer events might have been facilitated by their presence on mobile genetic elements.

Many of the resistance ribosomal protection proteins determinants such as tetQ and tetM are located on mobile genetic elements and this may have facilitated the spread of these genes throughout eubacteria via lateral gene transfer events21. In the current study, the tetQ gene, which is often associated with conjugative transposons in members of Bacteroidetes (Prevotella, Bacteroides, Parabacteroides, Paludibacter)21, represented the most dominant group of ARGs in the medicated animals, suggesting that the bacteria in the guts of medicated animals may become resistant mainly by acquisition of this gene.

As expected, oxytetracycline administration resulted in the enrichment of some tetracycline resistance genes, most likely due to a direct interaction. However, a collateral effect of antibiotic administration was observed, so that some ARGs that do not confer resistance toward oxytetracyline (e.g., rpoB, oxA, catP, TEM, mphA, cme, CTX, carB, gyrA, parE) also exhibited increased abundance with in-feed oxytetracycline, indicating an indirect mechanism of selection. Looft et al.6 suggested that this is likely due to co-presence of some ARGs on mobile genetic elements conferring resistance to antibiotic. Accordingly, further analysis in our study revealed that a majority of these enriched ARGs have been found on mobile genetic elements such as plasmids and integrons, which carry at least two other resistance genes (data not shown). The co-occurrence of ARGs on mobile genetic element could promote spread of these genes22 and could further facilitate horizontal transfer of these resistance gene clusters to potential human pathogens such as E. coli in the swine gut or the agricultural environment6. Together the results showed that in-feed oxytetracycline enriched the abundance of resistance genes specific to (and beyond) the administered antibiotic in the pig fecal microbiome.

Based on the analyses of the microbiota, we conclude that the fecal microbial diversity increases over time and shifted to an adult-type microbiota, which is consistent with previous studies made in pig23,24,25,26. Overall, Firmicutes and Bacteroidetes phyla were the predominate taxa in the fecal microbiota of the pigs, accounting for more than 90% of the bacterial population during the post weaning period24,27,28. Analysis also revealed that the therapeutic dose of oxytetracycline caused a reduction in overall species richness and diversity in the medicated animals and that the reduction lasted even after antibiotic administration was discontinued. Although the reduction was not statistically significant at the community level, the antibiotic treatment resulted in significant and enduring changes at the species level, indicating that a particular group of the microbial communities could confer greater resistance to perturbance induced by antibiotic than other gut microbiota members, which could be due to the specific effect the antibiotic29.

In this study, the most notable change in bacterial abundance was the increase in the abundances of Bacteroidetes and Proteobacteria during the first 7 days of oxytetracycline exposure, which was mainly observed as increased Prevotella, Parabacteroides, Paludibacter (Bacteroidetes) and Escherichia (Proteobacteria) abundances. Similar to our findings, ASP250 administration for three weeks has been shown to cause detectable divergence in the swine gut microbiota, including an increase in Proteobacteria abundance, which was correlated with increased Escherichia spp. abundance6. However, when amoxicillin and the β-lactamase inhibitor clavulanic acid were applied together, in the feed and via intramuscular injection, decreased E. coli abundance was observed in pigs30. Escherichia has been found to encode various ARGs, such as resistance genes for beta-lactams (cfxA3) and tetracycline (tetQ), genes for multidrug resistance (acrA, mdtH, mdtL and mdtO), and other genes (dimethyladenosine transferase)31. The phylum Bacteroidetes has been found to decrease in pigs fed tylosin32 and ASP2506, while carbadox administration has been reported to increase the abundance of this phylum during the early phase of administration4. An increase in the ratio of Bacteroidetes to Firmicutes proportion has been recently linked to increased short-chain fatty acid (SCFA) production in mice in response to fructo-oligosaccharide administration33. However, other studies have also highlighted possible negative impacts of enriched Bacteroidetes populations in the gut34,35. In terms of the gut resistome, the observed increase in the abundances of Prevotella, Parabacteroides, and Paludibacter in the medicated animals in the present study might be due to the potential of these taxa to carry ARGs that may be transferred to other susceptible bacteria in the densely populated microbial environment like the swine gut36,37.

Interestingly, previous studies have clearly highlighted the occurrence of tetracycline resistance genes (mainly tetQ) in taxa from Escherichia, Parabacteroides and Prevotella21,31,37,38. Recently, the relative abundances of Prevotella, Paludibacter, and Parabacteroides have been reported to be significantly correlated with the abundances of aminoglycoside, beta-lactam, MLS, sulfonamide, and tetracycline resistance genes and the abundances of transposases39. Blautia, Acidaminococcus and Megasphaera from Firmicutes were also found to be significantly enriched in the feces of the medicated swine. Blautia has been reported to harbor tetracycline resistance genes (tetQ, tetO, tet32, tetM) and a MLS resistance gene (ermB)31,38. Similarly, Acidaminococcus and Megasphaera have also been reported to carry tetracycline resistance genes (tetO, tetW)40,41. Overall, different patterns of shifts in microbial populations have been reported when different antibiotics were administered to pigs4,6,28,42, indicating that the effects of antibiotics on some microbial members are specific to the antibiotic being administered and depend on the varying collateral effects of different antibiotics.

In this study, the experimental design featured environmental controls such as host genetic control, no application of antibiotics to the sows or pigs to prior the experiment, and identical diet except for the inclusion of oxytetracycline for one treatment group. However, a limitation of the present study is that resistome profiling of the feeding trial facility environment as well as the feed samples in the pre and post weaning phase was not considered. The lack of this information may have impacted the accuracy of our findings to some extent. Despite this limitation, this study represents the first report on using shotgun metagenomics for studying dynamics of the gut microbiome and antibiotic resistome alterations in swine.

Further research is recommended to look beyond metagenomics-based resistome profiling and at effects on (AR) gene expression and even on the proteome and metabolome level. Additionally, given the widespread distribution of phages in the gut environment, the role of phages in the acquisition and spread of ARGs should be considered in future studies. Despite the recent observation that ARGs are rarely encoded in phage genomes43, the bacterium-phage interaction and subsequent (antibiotic resistance) gene transfer in the gut environment has not been fully investigated.

## Conclusions

In this study, the collateral effects of in-feed oxytetracycline administration at therapeutic dose on the pig fecal antibiotic resistome are observed. Even a short-term administration of oxytetracycline increased the abundance and diversity of ARGs, including those conferring resistance to antibiotics that were not administered, and increased the abundance of Proteobacteria, including E. coli population, a potential human pathogen. Although the effect of the therapeutic application on ARGs diminished over time, some ARGs remained significantly more abundant (q < 0.05) in medicated pigs than in the control group two weeks after the withdrawal of antibiotic administration.

## Materials and Methods

### Statement

The animal experiments were conducted under a protocol approved by the office of the Lower Austrian Region Government, Group of Agriculture and Forestry, Department of Agricultural Law (approval codes LF1-TVG-39/038-2016). The trial was carried out at the Center of Animal Nutrition (Tulln, Austria). All experiments and methods were conducted according to relevant guidelines and regulations.

### Animals and experimental design

Sixteen freshly weaned pigs (sow: Landrace × Large White, boar: Pietrain) that were 28 days old were selected for this study. Upon arrival the animals were individually housed and maintained in similar climatically controlled rooms. After four days of adaptation with ad libitum access to a standard starter diet (Table 1), the pigs were blocked (row-column design44) by sex (2) and ancestry (4), and within each block, the animals were randomly allocated to one of two treatments (n = 8 pigs/treatment): 1) standard starter diet for 21 days (control group) or 2) antibiotic-supplemented diet (10 g oxytetracycline Agrar-Service/100 KBW/day, corresponding to 40 mg oxytetracycline hydrochloride/KBW/day) for 7 days (recommended therapeutic dosage by the manufacturer). The treatment was followed by 14 days of standard starter diet (antibiotic group). For the duration of the study, the pigs were allowed ad libitum access to water and feed and all dietary treatments were equally represented in each room to remove any variation due to environmental factors.

### Fecal sampling, DNA extraction, library preparation and sequencing

Fecal materials were obtained from the individual pig by rectal stimulation on days 0 (before oxytetracycline treatment), 8 (after the oxytetracycline treatment), and 21 (two weeks after the withdrawal of oxytetracycline), and stored in sterile containers at –20 °C until processed. The total DNA was extracted from the fecal samples by the QIAamp PowerFecal Kit (Qiagen, Crawley, West Sussex, UK) following the manufacturer’s instructions with some modifications recommended by Hart et al.45. The final DNA were eluted in 100 μL of 10 mM Tris buffer (pH 8) after being incubated for 5 min for maximum elution efficiency. A Qubit fluorometer (Qubit 3, Invitrogen) was used to determine the total DNA concentration, and purity was assessed via the 260/280 and 260/230 absorbance ratios using a spectrophotometre (NanoDrop® ND-1000). The samples were sent for DNA sequencing to the Teagasc Food Research Centre, Ireland. Paired-end sequencing libraries were prepared from the extracted DNA using the Illumina Nextera XT Library Preparation Kit (Illumina Inc., San Diego, CA) followed by sequencing on the Illumina NextSeq 500 platform using high-output chemistry (2 × 150 bp) according to the manufacturer’s instructions.

### Sequence analysis

All bioinformatics and statistical analyses of the metagenome datasets were conducted with custom Bash, R, and Perl scripts using the existing softwares and algorithms. (see below).

### Quality filtering

Quality filtering of the metagenome datasets was carried out in several steps to remove sequencing adapters (cutadapt v. 1.1246), low-quality sequences with quality scores < 33 (fastx toolkit v. 0.0.14), reads mapped to the host genome (pig, NCBI accession no. NC 010443) (DeconSeq v. 0.4.347), and finally to remove any sequences mapped to the PhiX174 genome (NCBI accession no. NC 001422) (DeconSeq v. 0.4.347).

### Resistome annotation and comparison

To quantify the abundances of ARGs, 42 quality-filtered metagenomes were used for similarity searches against the hand-curated antimicrobial resistance database MEGARes48 by using USEARCH (v10)49. Containing the sequences of approximately 4,000 ARGs, the MEGARes database is based on a nonredundant compilation of sequences contained in ResFinder (November 2015), ARG-ANNOT (November 2015), the Comprehensive Antibiotic Resistance Database (CARD, v1.0.7), and the National Center for Biotechnology Information (NCBI) Lahey Clinic beta-lactamase archive (December 2015)48.

High confidence matches to the sequence in MEGARes database were obtained by considering the entire coverage of the query reads against ARGs genes with a identity threshold of 90% (parameters were set as “-usearch-global -id 0.9, maxaccepts 1, threads 50”), as suggested elsewhere17. For each antibiotic resistance determinant (ARD), the total number of aligned reads was counted followed by normalization to the length of the respective gene, in order to remove possible sequence length variations bias17. Further, the length-normalized counts were normalized to the bacterial 16S rRNA sequences number (obtained by employing Metaxa250) divided by the average length of the 16S gene to yield an approximation of the ARGs number per bacterial 16S rRNA17 (Equation 1).

$$Abundance=\sum _{1}^{n}\frac{{N}_{{\rm{AMR}} \mbox{-} {\rm{like}}\mathrm{sequence}}/{L}_{AMRreferencesequence}}{{N}_{16Ssequence}/{L}_{16Ssequence}}$$
(1)

### Taxonomic affiliation

The taxonomic compositions of the metagenome datasets were identified by extracting the bacterial 16S rRNA sequences with Metaxa2 version 2.0 using the default options50,51. Genus assignment of the extracted sequences was carried out using the Metaxa 2 curated database taking to the account the reliability score (>80) as well as the similarity threshold (>90% identity with the reference 16S rRNA sequence) and reported as relative abundance based on the total number of 16S rRNA counts in each metagenome sample.

### Statistical analysis

Ordination and log-fold changes in abundance were calculated in R (version 3.3.0). Ordination was performed with log-transformed normalized reads on 2 dimensions with the “phyloseq’s” ordinate function using Non-metric multidimensional scaling (NMDS) analysis52. On the completed ordination plots, separation between groups was tested with PerMANOVA53. Log-fold changes in abundance (of taxa and ARGs) between groups was determined by a negative binomial generalized linear model using DESeq2 version 1.17.1054 in R, considering random differences between the treatment groups at first sampling as covariates term in the model. Accordingly, treatment and sampling day were included as fixed factors, while blocks were considered as confounder variables (random factors) in the analysis. These main factors along with their interactions were also taken into the account to investigate richness (the number of unique taxa or ARGs) and Shannon diversity (the number and relative abundance of unique taxa or ARGs) in each sample using the lme4 package in R55. Statistical significance for differential abundance analysis was considered at FDR-corrected P ≤ 0.05 (where applicable) and shown as the q value. In all statistical analysis, the individual animal/pen was considered the experimental unit.

## Data Availability

The data are deposited in the NCBI Short Read Archive under BioSamples SAMN09209536- SAMN09209575, which are affiliated with BioProject PRJNA471402.

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

## References

1. 1.

Institute, A. H. Additives and their Uses. (Animal Health Institute, Bloomington, MN, 2012).

2. 2.

Sun, J. et al. Comparison of Fecal Microbial Composition and Antibiotic Resistance Genes from Swine, Farm Workers and the Surrounding Villagers. Scientific Reports 7, 4965 (2017).

3. 3.

Van Boeckel, T. P. et al. Global trends in antimicrobial use in food animals. Proceedings of the National Academy of Sciences 112, 5649–5654, https://doi.org/10.1073/pnas.1503141112 (2015).

4. 4.

Looft, T., Allen, H. K., Casey, T. A., Alt, D. P. & Stanton, T. B. Carbadox has both temporary and lasting effects on the swine gut microbiota. Front Microbiol 5, 276 (2014).

5. 5.

Allen, H. K., Levine, U. Y., Looft, T., Bandrick, M. & Casey, T. A. Treatment, promotion, commotion: antibiotic alternatives in food-producing animals. Trends Microbiol. 21, 114–119 (2013).

6. 6.

Looft, T. et al. In-feed antibiotic effects on the swine intestinal microbiome. Proc. Natl. Acad. Sci. USA 109, 1691–1696, https://doi.org/10.1073/pnas.1120238109 (2012).

7. 7.

Zhu, Y. G. et al. Diverse and abundant antibiotic resistance genes in Chinese swine farms. Proc. Natl. Acad. Sci. USA 110, 3435–3440 (2013).

8. 8.

Agga, G. E. et al. Effects of chlortetracycline and copper supplementation on antimicrobial resistance of fecal Escherichia coli from weaned pigs. Prev. Vet. Med. 114, 231–246 (2014).

9. 9.

Thakur, S. & Gebreyes, W. A. Prevalence and antimicrobial resistance of Campylobacter in antimicrobial-free and conventional pig production systems. J. Food Prot. 68, 2402–2410 (2005).

10. 10.

Keelara, S. et al. Longitudinal Study of Distributions of Similar Antimicrobial-Resistant Salmonella Serovars in Pigs and Their Environment in Two Distinct Swine Production Systems. Appl. Environ. Microbiol. 79, 5167–5178 (2013).

11. 11.

Granados-Chinchilla, F. & Rodríguez, C. Tetracyclines in Food and Feedingstuffs: From Regulation to Analytical Methods, Bacterial Resistance, and Environmental and Health Implications. Journal of Analytical Methods in Chemistry 2017, 1315497 (2017).

12. 12.

Chopra, I. & Roberts, M. Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiol. Mol. Biol. Rev. 65, 232–260 (2001).

13. 13.

Browne, H. P. et al. Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature 533, 543 (2016).

14. 14.

Union, E. In Official Journal of the European Union Vol. L 26829–43 (2003).

15. 15.

Maron, D. F., Smith, T. J. & Nachman, K. E. Restrictions on antimicrobial use in food animal production: an international regulatory and economic survey. Global Health 9, 48 (2013).

16. 16.

Koskella, B., Hall, L. J. & Metcalf, C. J. E. The microbiome beyond the horizon of ecological and evolutionary theory. Nat Ecol Evol (2017).

17. 17.

Pal, C., Bengtsson-Palme, J., Kristiansson, E. & Larsson, D. G. J. The structure and diversity of human, animal and environmental resistomes. Microbiome 4, 54 (2016).

18. 18.

Xiong, W. et al. Antibiotic-mediated changes in the fecal microbiome of broiler chickens define the incidence of antibiotic resistance genes. Microbiome 6, 34, https://doi.org/10.1186/s40168-018-0419-2 (2018).

19. 19.

Noyes, N. R. et al. Resistome diversity in cattle and the environment decreases during beef production. Elife 5, e13195 (2016).

20. 20.

Connell, S. R., Tracz, D. M., Nierhaus, K. H. & Taylor, D. E. Ribosomal Protection Proteins and Their Mechanism of Tetracycline Resistance. Antimicrob. Agents Chemother. 47, 3675–3681 (2003).

21. 21.

Leng, Z., Riley, D. E., Berger, R. E., Krieger, J. N. & Roberts, M. C. Distribution and mobility of the tetracycline resistance determinant tetQ. J. Antimicrob. Chemother. 40, 551–559 (1997).

22. 22.

Partridge, S. R., Kwong, S. M., Firth, N. & Jensen, S. O. Mobile Genetic Elements Associated with Antimicrobial Resistance. Clin. Microbiol. Rev. 31, e00088–00017, https://doi.org/10.1128/cmr.00088-17 (2018).

23. 23.

Zhang, Q., Widmer, G. & Tzipori, S. A pig model of the human gastrointestinal tract. Gut Microbes 4, 193–200 (2013).

24. 24.

Kim, H. B. et al. Longitudinal investigation of the age-related bacterial diversity in the feces of commercial pigs. Vet. Microbiol. 153, 124–133 (2011).

25. 25.

Schokker, D. et al. Long-Lasting Effects of Early-Life Antibiotic Treatment and Routine Animal Handling on Gut Microbiota Composition and Immune System in Pigs. PLOS ONE 10, e0116523 (2015).

26. 26.

Kraler, M., Ghanbari, M., Domig, K. J., Schedle, K. & Kneifel, W. The intestinal microbiota of piglets fed with wheat bran variants as characterised by 16S rRNA next-generation amplicon sequencing. Arch. Anim. Nutr. 70, 173–189 (2016).

27. 27.

Kim, H. B. et al. Microbial shifts in the swine distal gut in response to the treatment with antimicrobial growth promoter, tylosin. Proc. Natl. Acad. Sci. USA 109, 15485–15490 (2012).

28. 28.

Kim, H. B. & Isaacson, R. E. The pig gut microbial diversity: Understanding the pig gut microbial ecology through the next generation high throughput sequencing. Vet. Microbiol. 177, 242–251 (2015).

29. 29.

Pérez-Cobas, A. E. et al. Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PloS one 8, e80201–e80201, https://doi.org/10.1371/journal.pone.0080201 (2013).

30. 30.

Thymann, T. et al. Antimicrobial treatment reduces intestinal microflora and improves protein digestive capacity without changes in villous structure in weanling pigs. Br. J. Nutr. 97, 1128–1137, https://doi.org/10.1017/s0007114507691910 (2007).

31. 31.

Li, B. et al. Metagenomic and network analysis reveal wide distribution and co-occurrence of environmental antibiotic resistance genes. The Isme Journal 9, 2490 (2015).

32. 32.

Holman, D. B. & Chenier, M. R. Temporal changes and the effect of subtherapeutic concentrations of antibiotics in the gut microbiota of swine. FEMS Microbiol. Ecol. 90, 599–608 (2014).

33. 33.

De Vadder, F. et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84–96 (2014).

34. 34.

Ou, J. et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. The American Journal of Clinical Nutrition 98, 111–120 (2013).

35. 35.

Jalanka-Tuovinen, J. et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 63, 1737–1745 (2014).

36. 36.

Boente, R. F. et al. Detection of resistance genes and susceptibility patterns in Bacteroides and Parabacteroides strains. Anaerobe 16, 190–194 (2010).

37. 37.

Nakano, V. et al. Antimicrobial resistance and prevalence of resistance genes in intestinal Bacteroidales strains. Clinics 66, 543–547 (2011).

38. 38.

Forslund, K. et al. Country-specific antibiotic use practices impact the human gut resistome. Genome Res. 23, 1163–1169 (2013).

39. 39.

Zhou, Z. C. et al. Antibiotic resistance genes in an urban river as impacted by bacterial community and physicochemical parameters. Environ. Sci. Pollut. Res. Int. 24, 23753–23762 (2017).

40. 40.

Galán, J. C., Reig, M., Navas, A., Baquero, F. & Blázquez, J. ACI-1 from Acidaminococcus fermentans: Characterization of the First β-Lactamase in Anaerobic Cocci. Antimicrob. Agents Chemother. 44, 3144–3149 (2000).

41. 41.

Wang, H. H. & Schaffner, D. W. Antibiotic Resistance: How Much Do We Know and Where Do We Go from Here? Appl. Environ. Microbiol. 77, 7093–7095 (2011).

42. 42.

Allen, H. K. et al. Antibiotics in feed induce prophages in swine fecal microbiomes. MBio 2 (2011).

43. 43.

Enault, F. et al. Phages rarely encode antibiotic resistance genes: a cautionary tale for virome analyses. Isme j 11, 237–247, https://doi.org/10.1038/ismej.2016.90 (2017).

44. 44.

Shah, K. R. & Sinha, B. K. In Handbook of Statistics Vol. 13 903–937 (Elsevier, 1996).

45. 45.

Hart, M. L., Meyer, A., Johnson, P. J. & Ericsson, A. C. Comparative Evaluation of DNA Extraction Methods from Feces of Multiple Host Species for Downstream Next-Generation Sequencing. PLoS One 10, e0143334, https://doi.org/10.1371/journal.pone.0143334 (2015).

46. 46.

47. 47.

Schmieder, R. & Edwards, R. Fast identification and removal of sequence contamination from genomic and metagenomic datasets. PLoS One 6, e17288, doi:8 (2011).

48. 48.

Lakin, S. M. et al. MEGARes: an antimicrobial resistance database for high throughput sequencing. Nucleic Acids Res. 45, D574–D580 (2017).

49. 49.

Edgar, R. C. & Flyvbjerg, H. Error filtering, pair assembly and error correction for next-generation sequencing reads. Bioinformatics 31, 3476–3482 (2015).

50. 50.

Bengtsson-Palme, J. et al. metaxa2: improved identification and taxonomic classification of small and large subunit rRNA in metagenomic data. Molecular Ecology Resources 15, 1403–1414 (2015).

51. 51.

Bengtsson-Palme, J., Thorell, K., Wurzbacher, C., Sjöling, Å. & Nilsson, R. H. Metaxa2 Diversity Tools: Easing microbial community analysis with Metaxa2. Ecological Informatics 33, 45–50 (2016).

52. 52.

McMurdie, P. J. & Holmes, S. phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data. PLOS ONE 8, e61217 (2013).

53. 53.

Anderson, M. J. & Walsh, D. C. I. PERMANOVA, ANOSIM, and the Mantel test in the face of heterogeneous dispersions: What null hypothesis are you testing? Ecol. Monogr. 83, 557–574 (2013).

54. 54.

Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology 15, 550 (2014).

55. 55.

Bates, D., Mächler, M., Bolker, B. & Walker, S. Fitting Linear Mixed-Effects Models Using lme4. 2015 67, 48, https://doi.org/10.18637/jss.v067.i01 (2015).

## Acknowledgements

We thank Dr. Veronika Nagl, Birgit Antlinger, Iris Schantl, Aleksandra Koler, the Center for Applied Animal Nutrition (CAN) staff, Dr. Orla O’Sullivan (Teagasc) and Laura Finnegan (Teagasc) for their outstanding assistance and Dr. Johan Bengtsson-Palme for his helpful advice. This work was supported by the Austrian Research Promotion Agency (FFG) through the project Competence Headquarter (853863 & 859603).

## Author information

### Affiliations

1. #### BIOMIN Research Center, Tulln, Austria

• Mahdi Ghanbari
•  & Viviana Klose
2. #### Teagasc Food Research Centre, Moorepark, Fermoy, Cork, and APC Microbiome Ireland, Cork, Ireland

• Fiona Crispie
•  & Paul D. Cotter

### Contributions

M.G. performed analysis on all samples, interpreted data, wrote manuscript. P.C., V.K. and F.C. supervised development of work, helped in data interpretation and manuscript evaluation.

### Competing Interests

All authors declare no competing financial and non-financial interests, except MG and VK who are employed by BIOMIN Holding GmbH. BIOMIN is involved in natural feed additive development and research in natural alternatives of in-feed medication in livestock production.

### Corresponding author

Correspondence to Mahdi Ghanbari.

## Supplementary information

### DOI

https://doi.org/10.1038/s41598-019-40496-8